NasdaqCM - Nasdaq Real Time Price USD
ReShape Lifesciences Inc. (RSLS)
As of 10:05 AM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-8,666.00
-16,960.00
-21,902.00
-15,375.00
-8,550.00
Investing Cash Flow
--
-10.00
-92.00
1,855.00
-2,390.00
Financing Cash Flow
5,147.00
17,574.00
3,130.00
33,299.00
11,075.00
End Cash Position
1,148.00
4,559.00
3,955.00
22,815.00
3,007.00
Income Tax Paid Supplemental Data
22.00
10.00
5.00
102.00
40.00
Interest Paid Supplemental Data
--
--
--
296.00
--
Capital Expenditure
--
-43.00
-131.00
-352.00
-390.00
Issuance of Capital Stock
--
--
639.00
--
--
Issuance of Debt
--
--
--
1,000.00
10,455.00
Repayment of Debt
--
--
--
-10,500.00
--
Free Cash Flow
-8,666.00
-17,003.00
-22,033.00
-15,727.00
-8,940.00
12/31/2020 - 10/6/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HSCS HeartSciences Inc.
2.7500
0.00%
AIMD Ainos, Inc.
0.4310
-2.05%
INBS Intelligent Bio Solutions Inc.
1.3700
-2.74%
BBLG Bone Biologics Corporation
1.3291
+1.46%
VERO Venus Concept Inc.
0.4156
-4.15%
SINT Sintx Technologies, Inc.
2.9213
-0.30%
NAOV NanoVibronix, Inc.
0.5900
+3.69%
VTAK Catheter Precision, Inc.
0.4963
-2.69%
TNON Tenon Medical, Inc.
3.4465
+0.48%
ICCM IceCure Medical Ltd
0.8150
-4.12%